India imposes anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China
The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 3, 2020 Category: Pharmaceuticals Source Type: news

Test accurately IDs people whose gonorrhea can be cured with simple oral antibiotic
A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.In research published in the peer-reviewed journal Clinical Infectious Diseases,a UCLA-led team found thatof106 subjectsthe test identified as having a strain ofgonorrhea called wild-type gyrA serine, all were cured with a single dose of oral ciprofloxacin. Though the test has been available for three years, this is the first time it has been systematicall...
Source: UCLA Newsroom: Health Sciences - August 13, 2020 Category: Universities & Medical Training Source Type: news

Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin
MONDAY, Aug. 10, 2020 -- For patients with gonorrhea, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of a successful treatment outcome with ciprofloxacin, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 10, 2020 Category: Pharmaceuticals Source Type: news

New gonorrhea test identifies patients who will respond to oral antibiotic
A new test for gonorrhea can determine whether those infected will respond successfully to the inexpensive oral antibiotic ciprofloxacin, according to a study published Friday by Clinical Infectious Diseases. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 7, 2020 Category: Consumer Health News Source Type: news

CDC Issues Health Advisory on Meningococcal Disease
The CDC on June 18 issued a health advisory notifying physicians about recent case reports of patients with meningococcal disease that is resistant to both penicillin and ciprofloxacin. (Source: AAFP News)
Source: AAFP News - June 22, 2020 Category: Primary Care Source Type: news

Drug-Resistant Meningitis Found in Several US Patients Drug-Resistant Meningitis Found in Several US Patients
The CDC has identified 11 meningococcal isolates with evidence of resistance to penicillin and ciprofloxacin, according to a Health Alert Network health advisory.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 19, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020
This report describes a novel, antibiotic-resistant strain of Neisseria meningitidis bacteria that has been detected in the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 18, 2020 Category: American Health Tags: Antibiotic and Antimicrobial Resistance MMWR Morbidity & Mortality Weekly Report Meningococcal Disease Source Type: news

G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer
Women with early-stage breast cancer had a lower rate of febrile neutropenia when given G-CSF alongside their chemotherapy rather than ciprofloxacin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Seasonal Patterns of Ciprofloxacin Resistance in UTI Seasonal Patterns of Ciprofloxacin Resistance in UTI
Are there seasonal variations in resistance to fluoroqinolones and other antimicrobial agents among community-acquired urinary E. coli infections?American Journal of Epidemiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 5, 2020 Category: Intensive Care Tags: Public Health & Prevention Journal Article Source Type: news

MIT Scientists Identify Powerful Antibiotic Using Artificial Intelligence
BOSTON (CBS) — Bacteria are becoming increasingly resistant to antibiotics, but using artificial intelligence, scientists at Massachusetts Institute of Technology have developed a new powerful antibiotic. Only a few antibiotics have been developed in recent years because the process is costly and time-consuming. But researchers at MIT trained a computer to screen thousands of chemical compounds for their ability to kill bacteria with the low likelihood of hurting human cells. They found one they named halicin, after the AI system in the movie “2001: A Space Odyssey”. “MIT researchers used a machine-...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Antibiotics Artificial Intelligence Dr. Mallika Marshall Massachusetts Institute Of Technology Source Type: news

European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2017/2018
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/31/2020. Salmonella and campylobacter are becoming increasingly resistant to ciprofloxacin, one of the antibiotics of choice for treating infections caused by these bacteria. That conclusion is part of this 166-page report on antimicrobial resistance in zoonoses, released with the European Food Safety Authority (EFSA), which also presents some positive trends in the animal sector and includes key outcome indicators that will help European Union Member States assess their progress in reducing the use of antimicrobials and combat...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 31, 2020 Category: International Medicine & Public Health Source Type: news

Cipro vs. Flagyl
Title: Cipro vs. FlagylCategory: MedicationsCreated: 10/3/2017 12:00:00 AMLast Editorial Review: 1/10/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - January 10, 2020 Category: Drugs & Pharmacology Source Type: news

Meningococcal disease and ciprofloxacin: PGD template
This Patient Group Directive supports the supply or administration of ciprofloxacin to adults and children for the management of clusters of meningococcal disease, when 2 or more cases are reported in in educational or residential settings. It is valid from 30 August 2019 until 30 August 2022. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 19, 2019 Category: Consumer Health News Source Type: news

Antibiotics Tied to Heart Valve Problems
The class of antibiotics called fluoroquinolones (Cipro, Levaquin and others) may increase the risk of heart valve problems. (Source: NYT Health)
Source: NYT Health - September 17, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Antibiotics Heart Levaquin (Drug) Source Type: news

UCLA-led research reveals potential treatments for deadly tropical disease
Melioidosis is a tropical disease that claims an estimated 90,000 lives worldwide each year. There is no vaccine, and current treatments are hampered by the ability of the bacterium that causes the disease to resist even the strongest antibiotics.Hardy and lethal, that bacterium, Burkholderia pseudomallei, is classified by the Centers for Disease Control and Prevention as a potential bioweapon.UCLA-led research has identified two compounds that, based on tests on human cells and on mice, show potential for treating melioidosis. One is a widely used drug already approved by the U.S. Food and Drug Administration as an antifu...
Source: UCLA Newsroom: Health Sciences - September 11, 2019 Category: Universities & Medical Training Source Type: news

Common antibiotics may lead to condition that causes heart failure
People who use Ciprofloxacin and other fluoroquinolone antibiotics have a 2.4 times higher risk of developing aortic and mitral regurgitation due to blood backflow into the heart (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 10, 2019 Category: Consumer Health News Source Type: news

Ciprofloxacin and Hypoglycemia Risk in Non-diabetic Patients Ciprofloxacin and Hypoglycemia Risk in Non-diabetic Patients
Is there a causal relationship between ciprofloxacin and hypoglycemia in patients without diabetes?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 17, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Nitrofurantoin vs. Ciprofloxacin
Title: Nitrofurantoin vs. CiprofloxacinCategory: MedicationsCreated: 6/28/2019 12:00:00 AMLast Editorial Review: 6/28/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 28, 2019 Category: Drugs & Pharmacology Source Type: news

Amoxicillin vs. Cipro
Title: Amoxicillin vs. CiproCategory: MedicationsCreated: 5/29/2019 12:00:00 AMLast Editorial Review: 5/29/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 29, 2019 Category: Drugs & Pharmacology Source Type: news

Doxycycline vs. Cipro
Title: Doxycycline vs. CiproCategory: MedicationsCreated: 5/14/2019 12:00:00 AMLast Editorial Review: 5/14/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 14, 2019 Category: Drugs & Pharmacology Source Type: news

British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019)
Revisions to this guideline includes advice that, if antimicrobial susceptibility test results from all sites of infection are available prior to treatment and the isolate is sensitive to ciprofloxacin, then this should be used for treatment in preference to ceftriaxone. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 30, 2019 Category: Consumer Health News Source Type: news

FDA Warns About What Fluoroquinolone Antibiotics May Do To Your Aorta
This is not the first FDA warning about fluoroquinolones, a class of antibiotics that includes ciprofloxacin (otherwise known as Cipro) and levofloxacin (otherwise known as Levoquin). (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 22, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Levaquin, Cipro Tied to Deadly Heart Vessel Tears
The risk for rupture, or dissection, of the aorta, rises with the use of antibiotics in a class known as fluoroquinolones delivered by injection or as a pill. The drugs "should not be used in patients at increased risk unless there are no other treatment options available," the FDA said. (Source: WebMD Health)
Source: WebMD Health - December 21, 2018 Category: Consumer Health News Source Type: news

A Reappraisal of Ciprofloxacin Use in Infants and Children A Reappraisal of Ciprofloxacin Use in Infants and Children
This article provides a reassessment of pediatric ciprofloxacin utilization in light of the recent FDA drug safety communication.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Common antibiotic doctors say could give you organ failure
Debbi Kinrade, 57, from Northamptonshire who for six years has been living with the consequences of taking ciprofloxacin. She was prescribed the drug for a urinary tract infection. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Treating urinary tract infections with Cipro
Cipro is an antibiotic that doctors use to treat urinary tract infections (UTIs). For Cipro to work, people must take the full course of the drug and follow their doctor's instructions. But some people may be at risk of severe side effects if they take Cipro, and they may need to consider alternatives. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 7, 2018 Category: Consumer Health News Tags: Urinary Tract Infection Source Type: news

Zimbabwe:Drug Resistant Typhoid Is Real
[The Herald] This strain of typhoid is not responding to traditionally used medicines such as ciprofloxacin and health workers have resorted to using the last line of antibiotics, azithromycin in defence against typhoid while waiting for approvals to embark on mass vaccinations. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2018 Category: African Health Source Type: news

Ciprofloxacin May Up Likelihood of Aortic Dissection, Rupture
FRIDAY, Aug. 3, 2018 -- In a mouse model of moderate, sporadic aortic aneurysm and dissection (AAD), ciprofloxacin increases susceptibility to aortic dissection and rupture, according to a study published online July 25 in JAMA Surgery. Scott A.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 3, 2018 Category: Pharmaceuticals Source Type: news

The dark side of antibiotic ciprofloxacin
(Baylor College of Medicine) Researchers have found that ciprofloxacin, a widely prescribed antibiotic, increases the risk of tears and rupture on the main artery of the body, the aorta, in a mouse model of human aortic aneurysms and dissections, a disease that carries high risk of death from aortic rupture. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 25, 2018 Category: International Medicine & Public Health Source Type: news

Weekly Ciprofloxacin Noninferior to Daily Norfloxacin for Preventing Bacterial Peritonitis Weekly Ciprofloxacin Noninferior to Daily Norfloxacin for Preventing Bacterial Peritonitis
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Trial from Niger finds village-wide prophylactic antibiotics contained spread of meningitis
(PLOS) Distribution of single doses of the oral antibiotic ciprofloxacin to residents of rural villages in the African meningitis belt reduced the number of meningitis cases during a 2017 meningitis epidemic, according to a new study in PLOS Medicine by Matthew Coldiron and colleagues from Epicentre and M é decins Sans Fronti è res in France, Switzerland and Niger. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 26, 2018 Category: Infectious Diseases Source Type: news

Rise in Possible Fluoroquinolone-Resistant Shigella Isolates Rise in Possible Fluoroquinolone-Resistant Shigella Isolates
The CDC is seeing an increasing number of Shigella isolates that test within the susceptible range for the fluoroquinolone antibiotic ciprofloxacin but harbor one or more resistance mechanisms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 7, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Cipro HC Otic (Ciprofloxacin Hydrochloride Otic Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 14, 2018 Category: Drugs & Pharmacology Source Type: news

Antibiotics Tied to Higher Kidney Stone Risk
The five antibiotic classes newly linked to kidney stone risk included sulfas (Bactrim, Gantanol); cephalosporins (Keflex); fluoroquinolones (Cipro); nitrofurantoin/methenamine (Macrobid, Hiprex); and broad-spectrum penicillins. (Source: WebMD Health)
Source: WebMD Health - May 11, 2018 Category: Consumer Health News Source Type: news

Otonomy Announces FDA Approval of Otiprio (ciprofloxacin otic suspension) for Acute Otitis Externa
SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that the U.S. Food and Drug Administration (FDA) has approved... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 2, 2018 Category: Drugs & Pharmacology Source Type: news

Cipro, Cipro XR (ciprofloxacin) Antibiotic Side Effects
Title: Cipro, Cipro XR (ciprofloxacin) Antibiotic Side EffectsCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/26/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 26, 2018 Category: Drugs & Pharmacology Source Type: news

Bactrim vs. Cipro
Title: Bactrim vs. CiproCategory: MedicationsCreated: 2/16/2018 12:00:00 AMLast Editorial Review: 2/16/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 16, 2018 Category: Drugs & Pharmacology Source Type: news

High levels of antibiotic resistance found worldwide, new data show
BANGKOK 29 January 2018 – The World Health Organization’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries. WHO’s new Global Antimicrobial Surveillance System (known as GLASS) reveals widespread occurrence of antibiotic resistance among 500 000 people with suspected bacterial infections across 22 countries.  The most commonly reported resistant bacteria were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae, followed by Salmo...
Source: WHO EMRO News - January 29, 2018 Category: Middle East Health Source Type: news

FDA Panel Does Not Recommend Cipro Dispersion for Inhalation FDA Panel Does Not Recommend Cipro Dispersion for Inhalation
An FDA panel did not recommend ciprofloxacin dispersion for inhalation for non-cystic fibrosis bronchiectasis in patients with chronic lung infections with Pseudomonas aeruginosa.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 15, 2018 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Boosting the antibiotic arsenal
(Massachusetts Institute of Technology) MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 8, 2017 Category: International Medicine & Public Health Source Type: news

Can I Give Cholera Vaccine?
Discussion Cholera is caused by more than 200 serogroups of Vibrio cholerae, a Gram-negative rod that is waterborne. Only two (serogroup O1 which causes about 99% of the cases, and O139) cause disease. There are biotypes of each of these serotypes. The only known hosts are humans. The organism colonizes the epithelial lining of the gut. Cholera toxin is produced by some species and if produced binds to specific receptors on host cells, activating a series of steps which cases massive loss of sodium, potassium, chloride, hydrogen carbonate, and fluids in vomitus and feces. A review of causes of diarrhea can be found here. ...
Source: PediatricEducation.org - November 27, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Otiprio (Ciprofloxacin Otic Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

Cipro vs. Flagyl (Differences between Side Effects and Uses)
Title: Cipro vs. Flagyl (Differences between Side Effects and Uses)Category: MedicationsCreated: 10/3/2017 12:00:00 AMLast Editorial Review: 10/3/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 3, 2017 Category: Drugs & Pharmacology Source Type: news

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Growing evidence suggests that microbes can influence the efficacy of cancer therapies. By studying colon cancer models, we found that bacteria can metabolize the chemotherapeutic drug gemcitabine (2',2'-difluorodeoxycytidine) into its inactive form, 2',2'-difluorodeoxyuridine. Metabolism was dependent on the expression of a long isoform of the bacterial enzyme cytidine deaminase (CDDL), seen primarily in Gammaproteobacteria. In a colon cancer mouse model, gemcitabine resistance was induced by intratumor Gammaproteobacteria, dependent on bacterial CDDL expression, and abrogated by cotreatment with the antibiotic ciprofloxa...
Source: ScienceNOW - September 14, 2017 Category: Science Authors: Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., Thaiss, C. A., Reuben, A., Livny, J., Avraham, R., Frederick, D. T., Ligorio, M., Chatman, K., Johnston, S. E., Mosher, C. Tags: Medicine, Diseases reports Source Type: news

Ciprofloxacin Hydrochloride Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - September 8, 2017 Category: Drugs & Pharmacology Source Type: news

Aradigm lands NIH grant for inhaled, liposomal products
Aradigm Corp. (NSDQ:ARDM) said today that the National Institute of Allergy and Infectious Diseases and the NIH awarded the company a grant to study the treatment of pulmonary non-tuberculous mycobacteria infections with Aradigm’s inhaled liposomal ciprofloxacin products, Linhaliq and Lipoquin. The two-year grant is worth approximately $972,000, according to the Hayward, Calif.-based company. Get the full story at our sister site, Drug Delivery Business News. The post Aradigm lands NIH grant for inhaled, liposomal products appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 15, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Pharmaceuticals Respiratory Wall Street Beat Aradigm Corp. Source Type: news

Certain Antibiotics May Increase Risk of Birth Defects
Ciprofloxacin, levofloxacin and other drugs like them should be avoided in pregnancy, a study found. (Source: NYT Health)
Source: NYT Health - July 20, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Pregnancy and Childbirth Antibiotics Babies and Infants Birth Defects Source Type: news

Toothpaste ingredient linked to antibiotic resistance
Conclusion This study mainly explored why bacterial resistance could be common for both quinolone antibiotics like ciprofloxacin and the antibacterial triclosan. It confirmed previous findings that one cause seems to be bacteria developing mutations in the gyrA gene. In the case of quinolones, the mutation alters the enzyme that they normally bind to. Triclosan resistance is largely because the already-mutant bacteria have boosted stress response pathways, or molecular defences. The main finding of this research was that small triclosan concentrations led to resistant E. coli bacteria becoming the more dominant strains m...
Source: NHS News Feed - July 5, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Rapid Assay Revives Ciprofloxacin Use for Gonorrhea Rapid Assay Revives Ciprofloxacin Use for Gonorrhea
A pharmacogenomics approach identified gonorrhea infections susceptible to ciprofloxacin and allowed physicians to reserve ceftriaxone for resistant cases.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 3, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Scientists develop test to identify best treatment for gonorrhea
FINDINGSResearchers from UCLA have developed a laboratory test that helps physicians determine which people with gonorrhea may be more treatable with an antibiotic that has not been recommended since 2007 because of concerns that the resistance to the drug was growing.BACKGROUNDGonorrhea has developed increasing resistance to all current antibiotics. Due to the spread of multi-drug resistant gonorrhea, health authorities have declared it one of the top-three urgent threats to public health.Ciprofloxacin was used to combat the sexually transmitted infection until 2007, when the Centers for Disease Control and Prevention sto...
Source: UCLA Newsroom: Health Sciences - May 23, 2017 Category: Universities & Medical Training Source Type: news